Catalyst
Slingshot members are tracking this event:
Inovio Pharma to initiate Phase 3 trial of VGX-3100 for HPV-related cervical dysplasia in Q3 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| INO |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 24, 2016
Occurred Source:
http://ir.inovio.com/news/news-releases/news-releases-details/2016/Inovio-Announces-FDA-Request-for-Additional-Information-For-Phase-III-Program-Trial-Initiation-Delayed/default.aspx
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Trial, Cervical Dysplasia, Hpv, Hpv Infections, Cervical Cancer, Vgx-3100
